[Ethambutol-sensitivity of mycobacteria].
Explore the source record for details and available documents.
Drug Resistance, Microbial↗
Biomedical subjects
P Mancini
Publications and source records attributed to P Mancini.
[On the use of a new differential medium for typing mycobacteria].
Explore the source record for details and available documents.
Culture Media↗
[Drug resistance of Mycobacterium tuberculosis. Behavior of the phenomenon during the past 10 years].
Explore the source record for details and available documents.
Antitubercular Agents↗
[In vivo and in vitro experimental research on polyresistant Mycobacterium tuberculosis].
Explore the source record for details and available documents.
Animals↗
[Clinical research: course of pulmonary tuberculosis caused by polyresistant Mycobacterium tuberculosis].
Explore the source record for details and available documents.
Antitubercular Agents↗
[Terminal causes of death in patients suffering from pulmonary tuberculosis in relation to the drug sensitivity of the strains of Mycobacterium tuberculosis].
Explore the source record for details and available documents.
Antitubercular Agents↗
[Rifampicin and isoniazid in the intermittent treatment of experimental tuberculosis in guinea-pigs].
Explore the source record for details and available documents.
Animals↗
[Action of rifampicin on non-tubercular bacterial flora].
Explore the source record for details and available documents.
Anti-Bacterial Agents↗
[Drug sensitivity of the so-called atypical mycobacteria].
Explore the source record for details and available documents.
Aminosalicylic Acids↗
[On some aspects of antimycobacterial activity in vitro of cycloserine and terizidone].
Explore the source record for details and available documents.
Antitubercular Agents↗
[Clinical significance of the degree of resistance of tubercular mycobacteria to specific chemoantibiotics (clinical note)].
Explore the source record for details and available documents.
Adult↗
[Intermittent rifomycin therapy of experimental tuberculosis in guinea pigs].
Explore the source record for details and available documents.
Animals↗
[Intermittent ethambutol therapy of experimental tuberculosis in guinea pigs].
Explore the source record for details and available documents.
Animals↗
[Clinical significance of resistance of Mycobacterium tuberculosis to chemoantibiotics].
Explore the source record for details and available documents.
Animals↗
[Experimental research on the antimycobacterial activity of rifampicine: 3-(4-methyl-l-piperazinyl-iminomethyl)-rifomycin SV].
Explore the source record for details and available documents.
Animals↗
[Antitubercular serum antibodies revealed through immunofluorescence].
Explore the source record for details and available documents.
Animals↗
[Experimental research on the antimycobacterial activity of ethambutol].
Explore the source record for details and available documents.
Antitubercular Agents↗
Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations.
A sustained-release theophylline preparation in capsule form was compared with standard slow-release theophylline tablets for variation in plasma theophylline concentration, effectiveness and tolerability in 30 adults with chronic broncho-obstructive pathology. They were administered every 12 h and blood samples were collected after 8 days of treatment during the steady-state period. In this double-dummy crossover study, the sequence of the two regimens (sustained-release capsules versus tablets) was selected at random. The results of this study demonstrate that plasma theophylline levels remain within the therapeutic range for both preparations. Effectiveness and tolerability of the two drugs were satisfactory.
Adult↗